Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Acro Biomedical (ACBM) Other Operating Expenses (2016 - 2023)

Acro Biomedical (ACBM) has 5 years of Other Operating Expenses data on record, last reported at $492000.0 in Q3 2023.

  • For Q3 2023, Other Operating Expenses changed N/A year-over-year to $492000.0; the TTM value through Jun 2024 reached $492000.0, changed N/A, while the annual FY2023 figure was $492000.0, N/A changed from the prior year.
  • Other Operating Expenses reached $492000.0 in Q3 2023 per ACBM's latest filing, down from $2.1 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $2.1 million in Q3 2021 and bottomed at $282858.0 in Q3 2019.
  • Average Other Operating Expenses over 3 years is $966102.7, with a median of $492000.0 recorded in 2023.